Development and validation of liquid biopsy ddpcr and next generation sequencing assays for diffuse midline glioma, K27M variant
Ended Project Grant Awarded Last action
- Award ID
- R43CA247125
- Recipient
-
Resourcepath, LLC UEI PAJNWLGPK753
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,679
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Virginia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,679 |
Quick answers
Who received award R43CA247125?
R43CA247125 was awarded to Resourcepath, LLC by National Cancer Institute (National Institutes of Health) on September 11, 2019.
How much is award R43CA247125 worth?
$224,679 has been obligated on R43CA247125.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award